Clinical effect of meso‐tetrahydroxyphenylchlorine based photodynamic therapy in recurrent carcinoma of the ovary: preliminary results
- 1 March 1997
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 104 (3) , 376-378
- https://doi.org/10.1111/j.1471-0528.1997.tb11472.x
Abstract
This article addresses the use of meso-tetrahydroxyphenylchlorin-based photodynamic therapy (m-THPC-PDT) to treat recurrent gynaecologic malignancies of the ovary. Photodynamic therapy is an experimental approach in the treatment of neoplasms and results indicate it is a highly tissue selective, relatively simple intervention with few side effects, therefore reducing the overall burden on the patient. Of the three patients involved in the initial study, two were treated solely with photodynamic therapy by laparoscopy, and one underwent additional palliative debulking surgery of metastatic tumours. After a post-operative period of more than two years all three women remained free of relapses.Keywords
This publication has 6 references indexed in Scilit:
- Photoimmunotherapy and biodistribution with an OC125-chlorin immunoconjugate in an in vivo murine ovarian cancer modelBritish Journal of Cancer, 1994
- Effect of drug-light interval on photodynamic therapy with meta-tetrahydroxyphenylchlorin in malignant mesotheliomaInternational Journal of Cancer, 1993
- Photodynamic therapy of human ovarian epithelial carcinoma, OVCAR-3, heterotransplanted in the nude mouseAmerican Journal of Obstetrics and Gynecology, 1992
- HOW DOES PHOTODYNAMIC THERAPY WORK?Photochemistry and Photobiology, 1992
- Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical resultsBritish Journal of Cancer, 1991
- Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumour photosensitizersBiochemical Journal, 1989